Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Lockheed Martin Stock Soars on Earnings Beat – “We’re an arm of the U.S. government,” analyst quips

Lockheed Martin Stock Soars on Earnings Beat – “We’re an arm of the U.S. government,” analyst quips

Robust Q3 Results and Increased Guidance Lockheed Martin’s (NYSE:LMT) Oct. 21 earnings release blew past forecasts, reflecting surging military demand. Revenue rose 8.8% year-over-year to $18.61 billion and net income was $6.95/share seattlepi.com. That beat Wall Street’s $6.33/share estimate and matched
Alcoa (AA) Stock Poised for Breakout? Gallium Project, Tariff Relief & $40 Target Stun Investors

Alcoa (AA) Stock Poised for Breakout? Gallium Project, Tariff Relief & $40 Target Stun Investors

Alcoa’s stock story is a mix of bullish projects and market risks. The recent government-backed gallium plant (critical mineral for tech and defense) is a major positive, potentially diversifying Alcoa’s business beyond aluminium. Yet the industry is grappling with high
Stratasys (SSYS) Stock Surges 14%: Why 3D Printing Shares Are Heating Up

Stratasys (SSYS) Stock Surges 14%: Why 3D Printing Shares Are Heating Up

In summary, Stratasys’s stock has surged to multi-month highs on a combination of company-specific catalysts and broader market tailwinds. Recent acquisitions (Forward AM, Nexa3D), strategic partnerships (e.g. Toyota), and solid quarterly results have helped offset lingering macro uncertainty. Analysts remain
HeartCore (HTCR) Stock Soars on Dividend Surprise – Analysts Weigh In

HeartCore (HTCR) Stock Soars on Dividend Surprise – Analysts Weigh In

Stock Performance & Dividend Announcement HTCR’s stock surged on Oct. 20, 2025, when the company revealed the $0.13/share dividend globenewswire.com. In after-hours trading, the share price jumped roughly 40% investing.com. (According to Investing.com, HeartCore stock “surged 40% in after-hours trading
Beam Therapeutics Stock Soars on FDA Backing – Analysts Forecast ~70% Upside

Beam Therapeutics Stock Soars on FDA Backing – Analysts Forecast ~70% Upside

Ticker: Beam Therapeutics (NASDAQ: BEAM) globenewswire.com. – Price (Oct 21, 2025): ~$30 per share (about +17% recently) ts2.tech. – Sector: Biotechnology (precision gene editing) globenewswire.com. – Recent News: FDA granted Regenerative Medicine Advanced Therapy (RMAT) and Orphan Drug designations to
1 114 115 116 117 118 232
Go toTop